Original language | English |
---|---|
Pages (from-to) | e831-e859 |
Journal | The Lancet HIV |
Volume | 6 |
Issue number | 12 |
DOIs | |
Publication status | Published (VoR) - Dec 2019 |
Access to Document
Other files and links
Fingerprint
Dive into the research topics of 'Global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2017, and forecasts to 2030, for 195 countries and territories: A systematic analysis for the Global Burden of Diseases, Injuries, and Risk Factors Study 2017'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: The Lancet HIV, Vol. 6, No. 12, 12.2019, p. e831-e859.
Research output: Contribution to journal › Article › peer-review
TY - JOUR
T1 - Global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2017, and forecasts to 2030, for 195 countries and territories
T2 - A systematic analysis for the Global Burden of Diseases, Injuries, and Risk Factors Study 2017
AU - GBD 2017 HIV collaborators
AU - Frank, Tahvi D.
AU - Carter, Austin
AU - Jahagirdar, Deepa
AU - Biehl, Molly H.
AU - Douwes-Schultz, Dirk
AU - Larson, Samantha Leigh
AU - Arora, Megha
AU - Dwyer-Lindgren, Laura
AU - Steuben, Krista M.
AU - Abbastabar, Hedayat
AU - Abu-Raddad, Laith Jamal
AU - Abyu, Direslgne Misker
AU - Adabi, Maryam
AU - Adebayo, Oladimeji M.
AU - Adekanmbi, Victor
AU - Adetokunboh, Olatunji O.
AU - Ahmadi, Alireza
AU - Ahmadi, Keivan
AU - Ahmadian, Elham
AU - Ahmadpour, Ehsan
AU - Ahmed, Muktar Beshir
AU - Akal, Chalachew Genet
AU - Alahdab, Fares
AU - Alam, Noore
AU - Albertson, Samuel B.
AU - Alemnew, Birhan Tamene T.
AU - Alene, Kefyalew Addis
AU - Alipour, Vahid
AU - Alvis-Guzman, Nelson
AU - Amini, Saeed
AU - Anbari, Zohreh
AU - Anber, Nahla Hamed
AU - Anjomshoa, Mina
AU - Antonio, Carl Abelardo T.
AU - Arabloo, Jalal
AU - Aremu, Olatunde
AU - Areri, Habtamu Abera
AU - Asfaw, Ephrem Tsegay
AU - Ashagre, Alebachew Fasil
AU - Asmelash, Daniel
AU - Asrat, Anemaw A.
AU - Avokpaho, Euripide F.G.A.
AU - Awasthi, Ashish
AU - Awoke, Nefsu
AU - Ayanore, Martin Amogre
AU - Azari, Samad
AU - Badawi, Alaa
AU - Bagherzadeh, Mojtaba
AU - Banach, Maciej
AU - Barac, Aleksandra
N1 - Funding Information: Research reported in this publication was supported by the Bill & Melinda Gates Foundation, the National Institute on Aging (NIA) of the NIH (award P30AG047845), and the National Institute of Mental Health of the NIH (award R01MH110163). The content is solely the responsibility of the authors and does not necessarily represent the official views of the Bill & Melinda Gates Foundation or the NIH. We thank Jeffery W Eaton from Imperial College London for the thoughtful feedback on an earlier version of this report. L J Abu-Raddad acknowledges the support of the Qatar National Research Fund (NPRP 9-040-3-008) who provided the main funding for generating the data provided to the GBD and Institute for Health Metrics and Evaluation effort. A Awasthi acknowledges funding support from the Department of Science and Technology, Government of India through the INSPIRE Faculty scheme. T B?rnighausen acknowledges support by the Alexander von Humboldt Foundation through the Alexander von Humboldt Professor award, funded by the Federal Ministry of Education and Research; the Wellcome Trust; and from National Institute of Child Health and Human Development (NICHD) of NIH (R01-HD084233), NIA of NIH (P01-AG041710), National Institute of Allergy and Infectious Diseases (NIAID) of NIH (R01-AI124389 and R01-AI112339), and Fogarty International Center (FIC) of NIH (D43-TW009775). A Badawi acknowledges the support of the Public Health Agency of Canada. A Barac acknowledges support for research from the Project of Ministry of Education, Science and Technology of the Republic of Serbia (No. III45005). M S Bin Sayeed acknowledges support from the Australian Government Research and Training Scholarship for PhD degree at the Australian National University, Australia. F Carvalho acknowledges UID/MULTI/04378/2019 and UID/QUI/50006/2019 support with funding from Funda??o para a Ci?ncia e a Tecnologia, Minist?rio da Ci?ncia, Tecnologia e Ensino Superior through national funds. J W De Neve acknowledges support by the Alexander von Humboldt Foundation. L Degenhardt acknowledges support by Australian National Health and Medical Research Council Fellowships (1135991, 1041742) and is supported by National Institute on Drug Abuse of NIH grants (R01DA1104470). D Demissie acknowledges support from the Bill & Melinda Gates Foundation. K Deribe acknowledges support from the Wellcome Trust (grant number 201900) as part of his International Intermediate Fellowship. A P Kengne acknowledges support from the South African Medical Research Council. Y J Kim acknowledges support from the Office of Research and Innovation, Xiamen University Malaysia. M Kumar acknowledges support from the FIC of the NIH (K43TW010716). O Oladimeji acknowledges support from the Human Sciences Research Council, South Africa, FIC of the NIH, and the University of Namibia. A M Samy acknowledges support from a fellowship from the Egyptian Fulbright Mission Program. A E Schutte acknowledges financial support from the South African Medical Research Council and National Research Foundation SARChI Research Programme. K Shibuya acknowledges support and grants from Japan Ministry of Health, Labour and Welfare, and grants from King's College London during the conduct of the study. N Taveira acknowledges partial funding by Funda??o para a Ci?ncia e Tecnologia, Portugal, and Aga Khan Development Network - Portugal Collaborative Research Network in Portuguese speaking countries in Africa (project 332821690) and by the European and Developing Countries Clinical Trials Partnership (project RIA2016MC-1615). S Topp acknowledges support by Rising Star Early Career Researcher Award from James Cook University, QLD, Australia and a National Health and Medical Research Council Hot North Career Development Fellowship. M Yotebieng acknowledges partial support from the NIAID of NIH (U01AI096299) and NICHD of the NIH (R01H087993). Funding Information: Research reported in this publication was supported by the Bill & Melinda Gates Foundation , the National Institute on Aging (NIA) of the NIH ( award P30AG047845 ), and the National Institute of Mental Health of the NIH ( award R01MH110163 ). The content is solely the responsibility of the authors and does not necessarily represent the official views of the Bill & Melinda Gates Foundation or the NIH. We thank Jeffery W Eaton from Imperial College London for the thoughtful feedback on an earlier version of this report. L J Abu-Raddad acknowledges the support of the Qatar National Research Fund ( NPRP 9-040-3-008 ) who provided the main funding for generating the data provided to the GBD and Institute for Health Metrics and Evaluation effort. A Awasthi acknowledges funding support from the Department of Science and Technology, Government of India through the INSPIRE Faculty scheme. T Bärnighausen acknowledges support by the Alexander von Humboldt Foundation through the Alexander von Humboldt Professor award, funded by the Federal Ministry of Education and Research; the Wellcome Trust; and from National Institute of Child Health and Human Development (NICHD) of NIH ( R01-HD084233 ), NIA of NIH ( P01-AG041710 ), National Institute of Allergy and Infectious Diseases (NIAID) of NIH ( R01-AI124389 and R01-AI112339 ), and Fogarty International Center (FIC) of NIH ( D43-TW009775 ). A Badawi acknowledges the support of the Public Health Agency of Canada. A Barac acknowledges support for research from the Project of Ministry of Education, Science and Technology of the Republic of Serbia ( No. III45005 ). M S Bin Sayeed acknowledges support from the Australian Government Research and Training Scholarship for PhD degree at the Australian National University, Australia. F Carvalho acknowledges UID/MULTI/04378/2019 and UID/QUI/50006/2019 support with funding from Fundação para a Ciência e a Tecnologia, Ministério da Ciência, Tecnologia e Ensino Superior through national funds. J W De Neve acknowledges support by the Alexander von Humboldt Foundation. L Degenhardt acknowledges support by Australian National Health and Medical Research Council Fellowships ( 1135991 , 1041742 ) and is supported by National Institute on Drug Abuse of NIH grants ( R01DA1104470 ). D Demissie acknowledges support from the Bill & Melinda Gates Foundation. K Deribe acknowledges support from the Wellcome Trust ( grant number 201900 ) as part of his International Intermediate Fellowship. A P Kengne acknowledges support from the South African Medical Research Council. Y J Kim acknowledges support from the Office of Research and Innovation, Xiamen University Malaysia. M Kumar acknowledges support from the FIC of the NIH ( K43TW010716 ). O Oladimeji acknowledges support from the Human Sciences Research Council, South Africa, FIC of the NIH, and the University of Namibia. A M Samy acknowledges support from a fellowship from the Egyptian Fulbright Mission Program. A E Schutte acknowledges financial support from the South African Medical Research Council and National Research Foundation SARChI Research Programme. K Shibuya acknowledges support and grants from Japan Ministry of Health, Labour and Welfare, and grants from King's College London during the conduct of the study. N Taveira acknowledges partial funding by Fundação para a Ciência e Tecnologia, Portugal, and Aga Khan Development Network - Portugal Collaborative Research Network in Portuguese speaking countries in Africa (project 332821690) and by the European and Developing Countries Clinical Trials Partnership ( project RIA2016MC-1615 ). S Topp acknowledges support by Rising Star Early Career Researcher Award from James Cook University, QLD, Australia and a National Health and Medical Research Council Hot North Career Development Fellowship. M Yotebieng acknowledges partial support from the NIAID of NIH ( U01AI096299 ) and NICHD of the NIH ( R01H087993 ). Publisher Copyright: © 2019 The Author(s).
PY - 2019/12
Y1 - 2019/12
UR - http://www.scopus.com/inward/record.url?scp=85075667976&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85075667976&partnerID=8YFLogxK
U2 - 10.1016/S2352-3018(19)30196-1
DO - 10.1016/S2352-3018(19)30196-1
M3 - Article
C2 - 31439534
AN - SCOPUS:85075667976
SN - 2352-3018
VL - 6
SP - e831-e859
JO - The Lancet HIV
JF - The Lancet HIV
IS - 12
ER -